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Abstract It is expected that hormone-sensitive lipase (HSL), 
like most other lipases and esterases, adopts an a/ß-hydrolase 
fold and has a catalytic triad of serine, aspartic or glutamic acid, 
and histidine. Recently, we have published a three-dimensional 
model for the C-terminal catalytic domain of HSL, having an a] 
ß-hydrolase fold and with Ser-4231, Asp-703 and His-733 in the 
catalytic triad (Contreras et al. (1996) J. Biol. Chem. 271, 
31426-31430). It has been shown that Ser-423, situated in the 
motif GXSXG, is essential for catalysis (Holm et al. (1994) 
FEBS Lett. 344, 234-238). The suggested aspartic acid and 
histidine were here probed by site-directed mutagenesis. Mu-
tants of residues Asp-703 and His-733 are devoid of both lipase 
and esterase activity, which is not the case for mutants of other 
tested aspartic acid and histidine residues. Thus, the presented 
data support the three-dimensional model structure with Asp-
703 and His-733 as part of the triad. 
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1. Introduction 
Hormone-sensitive lipase (HSL) is a key enzyme in lipid 
metabolism and overall energy homeostasis, since it catalyzes 
the rate-limiting step in mobilization of triglycerides in adi-
pose tissue (for reviews see [1-3]). HSL is under hormonal and 
neuronal control, involving activation through phosphoryla-
tion by the cAMP-dependent protein kinase [4,5]. The rat 
HSL cDNA has been cloned [6], sequenced [6,7] and ex-
pressed in COS cells [8] as well as in insect cells [9]. The latter 
has enabled purification of milligram amounts of highly pure 
HSL for studies of its structure-function relationships. 
Common features of lipases and several esterases are that 
they adopt the so-called a/ß-hydrolase fold [10] and perform 
catalysis using a catalytic triad consisting of a serine, aspartic 
or glutamic acid, and histidine (for reviews see [11,12]). Se-
quence alignment of HSL and Moraxella TA144 lipase 2, 
together with limited proteolysis and denaturation studies per-
formed with recombinant HSL, suggested that HSL is formed 
by at least two structural domains [9]. Of these, the C-terminal 
domain was expected to have the a/ß-hydrolase fold and ac-
commodate the hydrolytic capacity [9]. Further analysis of 
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HSL sequence and prediction of secondary structure elements 
revealed that the C-terminal domain is evolutionary related to 
enzymes of the esterase B family [13]. By comparing the pre-
dicted secondary structure elements with those of lipases and 
esterases of known structure from the esterase B family (Geo-
trichum candidum lipase, Candida rugosa lipase and Torpedo 
californica acetylcholine esterase), we have very recently built 
a three-dimensional model for the catalytic core of HSL [13]. 
One direct consequence of the structural model was the pro-
posal of a complete catalytic triad: Ser-4231, Asp-703 and 
His-733. Ser-423 is situated in a GXSXG motif, which is 
conserved around the active site serine in a large number of 
lipases and esterases. This residue has previously been probed 
by site-directed mutagenesis, and data from these analyses 
clearly identified Ser-423 as essential for both lipase and es-
terase activity of HSL [7]. Alignment of HSL and several 
other lipases and esterases including Moraxella TA144 li-
pase 2 [9,14], clearly support that the active site histidine is 
His-733, although no experimental data has been presented. 
In addition to the active site histidine and aspartic acid pro-
posed by the model, there are alternatives that should be 
considered. A suggested motif GXXXXDG, for the active 
site aspartic acid of some lipases [11], is found at Asp-445 
in HSL. Furthermore, it has also been suggested that a 17.6 
kDa peptide, spanning amino acids 333 to 499, is a catalyti-
cally active core in HSL [15]. The only conserved histidine in 
this peptide, after the active site serine, is His-493 which con-
sequently should be the active site histidine. 
In the present work, the different candidate aspartic acid 
and histidine residues of the catalytic triad in HSL were 
probed by site-directed mutagenesis in order to provide exper-
imental evidence on components of the active site. The val-
idity of our structural model for the catalytic domain was 
further tested by this approach. 
2. Materials and methods 
2.1. Site-directed mutagenesis 
Rat HSL cDNA, in the eukaryotic expression vector pSVL (Phar-
macia) [8], was subjected to site-directed mutagenesis at codons for 
conserved aspartic acid and histidine residues. The mutations were 
introduced using the overlap extension method [16], as previously 
described [7]. High-fidelity Vent DNA polymerase (New England Bi-
olabs) was used in order to minimize the occurrences of undesired 
mutations. A cassette approach [17] was used to replace fragments 
of the wild-type HSL cDNA by equivalent PCR-generated fragments 
containing the desired mutation. 
2.2. DNA sequencing 
The identity of each mutant and the absence of possible undesired 
mutations was confirmed by PCR-based automated DNA sequencing, 
using Taq DyeDeoxy Terminator Cycle sequencing kit (Applied Bio-
systems) and a model 373A DNA sequencer (Applied Biosystems), 
according to instructions by the manufacturer. 
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2.3. Transfection and expression of HSL cDNA 
Transfection and expression of wild-type and mutant rat HSL 
cDNAs in COS cells was accomplished by the lipofectin method as 
previously described [8]. For each construct, 5 ug of DNA was used to 
transfect 80% confluent COS cells in 60 mm plates. Transfections were 
performed in triplicate and at least two independent experiments were 
carried out for each construct. Cells were harvested 72 h after trans-
fection. The cells were rinsed with phosphate-buffered saline, dis-
rupted by a freeze/thawing cycle, and resuspended in 600 ul of 0.25 
M sucrose, 1 mM EDTA, 1 mM dithioerythritol, 20 ug/ml leupeptin, 
2 (tg/ml antipain and 1 |ig/ml pepstatin. Cell debris was removed by 
centrifugation at 12 000Xg for 2 min, and the supernatant was ana-
lyzed for protein concentration, lipase and esterase activity and HSL 
mass. 
2.4. Analysis of mutants 
Total protein in the supernatants was measured by a modified 
Lowry method [18]. Lipase activity was measured, by hydrolysis of 
l(3)-mono-[3H]oleoyl-2-0-monooleyl glycerol (MOME), a diglyceride 
ether analog, in a phospholipid stabilized emulsion, and esterase ac-
tivity by hydrolysis of 0.5 mM p-nitrophenyl butyrate (PNPB) as 
described [9]. Background activities in the COS cells were determined 
from cells transfected with pSVL alone. All the analyses were done in 
triplicate. 
2.5. Western blot analysis 
The HSL mass was estimated by Western blot analysis. Briefly, 30 
|xg of total protein (15-20 al) was subjected to SDS-PAGE using the 
Tris-tricine buffer system [19] and blotted onto nitrocellulose mem-
branes (Hybond-C extra, Amersham) using standard procedures. 
Membranes were blocked for at least 2 h in 20 mM Tris-HCl, pH 
7.6. 137 mM NaCl supplemented with 5% defatted milk powder. All 
following washes were done 3 times, for 5 min each, in the same buffer 
with 2.5% milk powder and 0.25% Tween-20 (Bio-Rad). After block-
ing, membranes were washed and incubated with polyclonal chicken 
anti-rat HSL IgG for 2 h, followed by washing and incubation for 1 h 
with rabbit anti-chicken antibody IgG. After a new wash, membranes 
were incubated with 125I-labeled goat anti-rabbit antibody IgG for 1 h, 
washed and dried. Membranes were analyzed by digital imaging using 
a Fujix Bas 2000 Imager (Fuji). Electrophoresis and blotting were 
performed with different amounts of recombinant rat HSL in separate 
lanes in order to verify the linearity of the method for HSL. 
3. Results and discussion 
with the lipid substrate interface. Mutating Asp-703 to aspar-
agine also resulted in a complete inactivation of the enzyme. 
However, when the conservative mutation Asp-703-Glu was 
analyzed, the activity was dramatically reduced, but the pos-
sibility of some residual activity could not be ruled out 
(P = 0.013 vs. pSVL; Fig. 2). It is, however, not unusual that 
conservative substitution of the acidic residue of the triad does 
not completely inactivate lipases. This has been observed with 
both pancreatic lipase [21,22] and G. candidum lipase [23]. 
Mutants of Asp-445, Asp-517, His-493 and His-696 are only 
mildly affected in their activities (Fig. 2). Indeed, the Asp-517-
Asn mutant is more active than wild-type HSL, especially 
with respect to esterase activity. When background activity 
is subtracted, Asp-517-Asn has approximately 1.7 times the 
esterase activity of wild-type HSL. The activity data clearly 
support that it is Asp-703 and His-733 that are important for 
catalysis and, therefore, possibly form part of the catalytic 
triad. In contrast, both alternative residues (Asp-445 and 
His-493) are largely unaffected by mutagenesis. The fact that 
mutating His-493 does not affect HSL activities strongly sug-
gests that the 17.6 kDa fragment proposed by others to be the 
catalytic core [15] cannot have catalytic activity per se. The 
PNPB hydrolyzing activity described for this fragment [15] 
may in fact be due to the interaction of several proteolytic 
fragments, held together by inter-atomic forces even after the 
cleavage of the peptide chain [9]. 
In order to verify the correct expression of the different 
HSL constructs, Western blot analyses were performed on 
the cell supernatants. Fig. 3 shows a representative Western 
blot, with one lane for each construct. Wild-type HSL and all 
HSL mutants appear as an 84 kDa band, as expected, and this 
band is absent in supernatants of cells transfected with pSVL 
alone. Interestingly, the HSL bands corresponding to the Asp-
703 mutants are weaker than those obtained for the rest of the 
mutants and the wild-type (~30% of wild-type HSL; Fig. 3). 
This observation was consistent in all experiments performed, 
and probably reflects a reduced stability of the mutant protein 
In order to probe the different candidate residues as to the 
active site aspartic acid and histidine in HSL, and to obtain 
experimental data to support our model for the catalytic core 
of this enzyme [13], residues Asp-445, Asp-703, His-493 and 
His-733 in rat HSL were subjected to site-directed mutagene-
sis. As further control residues, the conserved Asp-517 and 
His-696 were also mutated. Fig. 1 shows a schematic repre-
sentation of the structural model for the catalytic core of 
HSL. The residues that were mutated in this work are shown 
in ball-and-stick representation, with the exception of His-493 
and Asp-517. These two residues are located outside the re-
gion modeled, in an external module located between strands 
ß6 and ß7 [13]. Aspartic acid residues were mutated to aspar-
agine and/or glutamic acid and histidines to serine and/or 
alanine in order to minimize the disturbance of protein struc-
ture [20]. Wild-type and mutant HSL proteins were expressed 
individually in COS cells. The activities of wild-type and HSL 
mutants were analyzed in cell homogenate supernatants as 
described under Section 2. Fig. 2 shows the lipase (A) and 
esterase (B) activities of COS cell supernatants containing 
wild-type or mutant HSL. Mutants of His-733 lack any de-
tectable lipase or esterase activity. Since both lipase and ester-
ase activities are affected, it is clear that the mutations disturb 
the hydrolytic capacity rather than the interaction of HSL 
Fig. 1. Schematic representation of the structural model of HSL C-
terminal catalytic domain. The expected catalytic triad and other 
residues that were mutated in this work are shown in ball-and-stick 
representation. The figure was made with RasMol [25]. 
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Fig. 2. Lipase and esterase activities of COS cells transfected with different HSL mutants. pSVL plasmids containing rat HSL cDNAs encoding 
mutations of the indicated residues were used to transfect COS cells. Three days after transfection, the cells were analyzed for lipase activity 
(A) and esterase activity (B). The bars represent the mean ± SD from three plates, and each determination was in triplicate. None of the mu-
tants of residues Asp-703 and His-733 showed any significant lipase or esterase activity compared with the control cells transfected with pSVL 
alone (P>0.05, Student's Mest), with the possible exception of Asp-703-Glu (P = 0.013). Mutants are denoted with the residue number, fol-
lowed by one letter code amino acids indicating the wild-type residue and the mutation made. 
in the COS cells. It is not an unusual phenomenon that the 
stability of lipases and esterases is affected by mutating the 
active site carboxylic acid. It has, for example, been observed 
for pancreatic lipase [21], G. candidum lipase [23] and acetyl-
choline esterase [24]. Due to their polar character, aspartic 
(and glutamic) acid residues are usually involved in the for-
mation of ion and/or hydrogen bonding that contribute to the 
stability of the folding. Thus, the carboxylic acid of the triad 
participates often in bonding to several residues near the ac-
tive site, including the histidine (and in some cases even water 
molecules), playing a role not only in catalysis, but also in 
stabilizing the enzyme (see [12]). In our structural model for 
the catalytic domain of HSL it can be foreseen that Asp-703 
may form hydrogen bonds to several close residues, similar to 
what is observed in the crystal structure of G. candidum lipase, 
C. rugosa lipase and T. californica acetylcholine esterase. 
In summary, we have herein probed different candidate 
residues for the catalytic triad of HSL by site-directed muta-
genesis. The results clearly show that Asp-703 and His-733 are 
essential for the lipase and esterase activities of HSL, whereas 
Asp-455 and His-493 are not. These results provide experi-
mental support that Asp-703 and His-733, together with the 
previously identified Ser-423 [7], constitute the catalytic triad 
of HSL, as proposed in our structural model for the catalytic 
domain of HSL. 
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